252 related articles for article (PubMed ID: 23327801)
21. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto's thyroiditis.
Shi Y; Wang H; Su Z; Chen J; Xue Y; Wang S; Xue Y; He Z; Yang H; Zhou C; Kong F; Liu Y; Yang P; Lu L; Shao Q; Huang X; Xu H
Scand J Immunol; 2010 Sep; 72(3):250-5. PubMed ID: 20696023
[TBL] [Abstract][Full Text] [Related]
22. Effect of methimazole treatment for 2 years on circulating IL-4, IgE, TBII, and TSAb in patients with hyperthyroid Graves' disease.
Yamada T; Komiya I; Miyahara Y; Komatsu M; Shima I; Inazawa T; Aizawa T
Endocr J; 2006 Dec; 53(6):783-8. PubMed ID: 16983180
[TBL] [Abstract][Full Text] [Related]
23. Elevated interferon regulatory factor 4 levels in patients with allergic asthma.
Chen X; Gao YD; Yang J
J Asthma; 2012 Jun; 49(5):441-9. PubMed ID: 22515488
[TBL] [Abstract][Full Text] [Related]
24. Expression of IL-27, Th1 and Th17 in patients with aplastic anemia.
Du HZ; Wang Q; Ji J; Shen BM; Wei SC; Liu LJ; Ding J; Ma DX; Wang W; Peng J; Hou M
J Clin Immunol; 2013 Feb; 33(2):436-45. PubMed ID: 23054344
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of cytokines in children and adolescents with Graves' disease and non-toxic nodular goiter.
Bossowski A; Urban M
J Pediatr Endocrinol Metab; 2001 Jun; 14(6):741-7. PubMed ID: 11453524
[TBL] [Abstract][Full Text] [Related]
26. IL-14 and IL-16 are expressed in the thyroid of patients with either Graves' disease or Hashimoto's thyroiditis.
Kemp EH; Ajjan RA; Metcalfe RA; Watson PF; Weetman AP
Clin Endocrinol (Oxf); 2015 Nov; 83(5):726-32. PubMed ID: 25940130
[TBL] [Abstract][Full Text] [Related]
27. Clinical efficacy of Yingliu mixture combined with metimazole for treating diffuse goitre with hyperthyroidism and its impact on related cytokines.
Yang H; Cong Y; Wu T; Tang H; Ma M; Zeng J; Zhang W; Lian Z; Yang X
Pharm Biol; 2017 Dec; 55(1):258-263. PubMed ID: 27927064
[TBL] [Abstract][Full Text] [Related]
28. Myeloid related proteins are up-regulated in autoimmune thyroid diseases and activate toll-like receptor 4 and pro-inflammatory cytokines in vitro.
Peng S; Sun X; Wang X; Wang H; Shan Z; Teng W; Li C
Int Immunopharmacol; 2018 Jun; 59():217-226. PubMed ID: 29656212
[TBL] [Abstract][Full Text] [Related]
29. Low regulatory T cell and high IL-17 mRNA expression in a mouse Graves' disease model.
Yuan Q; Zhao Y; Zhu X; Liu X
J Endocrinol Invest; 2017 Apr; 40(4):397-407. PubMed ID: 27822606
[TBL] [Abstract][Full Text] [Related]
30. Increase of interferon-γ inducible CXCL9 and CXCL11 serum levels in patients with active Graves' disease and modulation by methimazole therapy.
Antonelli A; Ferrari SM; Corrado A; Ferrannini E; Fallahi P
Thyroid; 2013 Nov; 23(11):1461-9. PubMed ID: 23721189
[TBL] [Abstract][Full Text] [Related]
31. Expression of Th-17 and RORγt mRNA in Behçet's Disease.
Hamzaoui K; Bouali E; Ghorbel I; Khanfir M; Houman H; Hamzaoui A
Med Sci Monit; 2011 Apr; 17(4):CR227-34. PubMed ID: 21455110
[TBL] [Abstract][Full Text] [Related]
32. Upregulated tissue expression of T helper (Th) 17 pathogenic interleukin (IL)-23 and IL-1β in Hashimoto's thyroiditis but not in Graves' disease.
Zake T; Skuja S; Kalere I; Konrade I; Groma V
Endocr J; 2019 May; 66(5):423-430. PubMed ID: 30814438
[TBL] [Abstract][Full Text] [Related]
33. Thyrostatic drugs act through modulation of thyroid cell activity to induce remissions in Graves' disease.
Volpé R; Karlsson A; Jansson R; Dahlberg PA
Acta Endocrinol Suppl (Copenh); 1987; 281():305-11. PubMed ID: 2441553
[No Abstract] [Full Text] [Related]
34. Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy.
Yu SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Thyroid; 2017 Sep; 27(9):1185-1193. PubMed ID: 28805160
[TBL] [Abstract][Full Text] [Related]
35. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
36. Increased serum soluble Fas in patients with Graves' disease.
Hiromatsu Y; Bednarczuk T; Soyejima E; Miyake I; Yang D; Fukazawa H; Nonaka K
Thyroid; 1999 Apr; 9(4):341-5. PubMed ID: 10319938
[TBL] [Abstract][Full Text] [Related]
37. Th17 and Treg cells in adolescents with Graves' disease. Impact of treatment with methimazole on these cell subsets.
Klatka M; Grywalska E; Partyka M; Charytanowicz M; Kiszczak-Bochynska E; Rolinski J
Autoimmunity; 2014 May; 47(3):201-11. PubMed ID: 24443787
[TBL] [Abstract][Full Text] [Related]
38. Circulating Exosomes From Patients With Graves' Disease Induce an Inflammatory Immune Response.
Cui X; Huang M; Wang S; Zhao N; Huang T; Wang Z; Qiao J; Wang S; Shan Z; Teng W; Li Y
Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33367747
[TBL] [Abstract][Full Text] [Related]
39. Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditis.
Song RH; Yu ZY; Qin Q; Wang X; Muhali FS; Shi LF; Jiang WJ; Xiao L; Li DF; Zhang JA
Int J Clin Exp Pathol; 2014; 7(7):4024-31. PubMed ID: 25120780
[TBL] [Abstract][Full Text] [Related]
40. Serial analysis of the effects of methimazole or radical therapy on circulating CD16/56 subpopulations in Graves' disease.
Rojano J; Sasián S; Gavilán I; Aguilar M; Escobar L; Girón JA
Eur J Endocrinol; 1998 Sep; 139(3):314-6. PubMed ID: 9758442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
